| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 50.9497 | 51 |
| GSM780708 | Untreated after 4 days (C2_1) | 50.1023 | 49 |
| GSM780709 | Untreated after 4 days (C3_1) | 47.9612 | 41 |
| GSM780719 | Untreated after 4 days (C1_2) | 46.5075 | 34 |
| GSM780720 | Untreated after 4 days (C2_2) | 50.4619 | 50 |
| GSM780721 | Untreated after 4 days (C3_2) | 50.4972 | 50 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 49.5393 | 47 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 44.1779 | 23 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 43.1844 | 18 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 45.1416 | 28 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 46.8765 | 36 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 46.1299 | 33 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 48.3718 | 43 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 51.3961 | 52 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 46.9161 | 36 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 45.5485 | 30 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 49.5783 | 47 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 52.1682 | 54 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 49.6956 | 47 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 47.6098 | 39 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 53.4501 | 57 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 47.7862 | 40 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 49.7664 | 48 |